01.10.2024 - 03.10.2024Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Conference themes There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.
Speakers: Andrew Geall, Co-Founder and Chief Development Officer, Replicate Bioscience, Anna Perdrix, Founder and Co-Chief Executive Officer, Sixfold Bioscience, and more